Fundz

Sunshine Biopharma, Inc reported raising $8 Million in an initial SEC Form D filing, from an offering of $8 Million

PUBLIC · SBFMMar 18, 2022

Amount Raised

$8 Million

$8 Million sold, per SEC Form D (first sale Mar 18, 2022)

Round Type

Venture

Fort LauderdaleHealthcareHealth Care

Quick answer

Sunshine Biopharma raised $8 Million in a funding round, dated March 18, 2022. Sunshine Biopharma is based in Fort Lauderdale, Florida, United States.

How much did Sunshine Biopharma raise?
Sunshine Biopharma raised $8 Million in a funding round on March 18, 2022.
What does Sunshine Biopharma do?
Sunshine Biopharma is a pharmaceutical company that focuses on researching and offering life-saving medicines across various therapeutic areas, including oncology and antivirals.
Where is Sunshine Biopharma based and how big is it?
Sunshine Biopharma is based in Fort Lauderdale, Florida, United States. Fundz records about 44 employees.
Who are the decision-makers at Sunshine Biopharma?
Fundz holds 1 contact at Sunshine Biopharma, including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Health Care around the same time

Companies in the same sectors as Sunshine Biopharma that raised within 45 days of this round, from Fundz verified event records.

  • Treace raised $150M (Debt Financing) on May 2, 2022.
  • Hello Heart raised $70M (Series D) on May 2, 2022.
  • Agitated Solutions raised $515K on May 2, 2022.
  • Zetagen Therapeutics raised $9.6M on April 29, 2022.
  • Wellvana raised $20M on April 27, 2022.
  • ROM Technologies raised $201K (Seed) on April 26, 2022.

Who to call at Sunshine Biopharma, and when

A new round usually means Sunshine Biopharma is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Sunshine Biopharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Sunshine Biopharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Sunshine Biopharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Sunshine Biopharma

Location

333 Las Olas Way, Cu4 Suite 433

Fort Lauderdale, Florida, United States

About

Sunshine Biopharma is a pharmaceutical company that focuses on researching and offering life-saving medicines across various therapeutic areas, including oncology and antivirals.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Sunshine Biopharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsSteve S., Executive Officer, DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Sunshine Biopharma's next move

See what Strategic adds

Sunshine Biopharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.